Oppenheimer Initiates Coverage On Viatris with Outperform Rating, Announces Price Target of $25
9/23/2026
Impact: 70
Healthcare
Oppenheimer analyst Les Sulewski has initiated coverage on Viatris (NASDAQ: VTRS) with an Outperform rating. The firm has set a price target of $25 for the company's stock.
AI summary, not financial advice
Share: